Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review
Metrics: PDF 48 views | ?
1Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy
2National Center of Oncological Hadrontherapy (Fondazione CNAO), Pavia, Italy
#Co-first senior authors
Published: August 04, 2022
Copyright: © 2022 Rubatto et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Consent was added to this article: The patient mentioned in the paper signed the informed consent statement on 13/10/2020.
Original article: Oncotarget. 2021; 12:1116–1121. DOI: https://doi.org/10.18632/oncotarget.27966
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.